KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 87 filers reported holding KRYSTAL BIOTECH INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,008,428 | -3.1% | 2,629,383 | -1.9% | 0.03% | 0.0% |
| Q2 2023 | $314,819,487 | -10.5% | 2,681,597 | -39.0% | 0.03% | +62.5% |
| Q1 2023 | $351,776,914 | +110.6% | 4,393,916 | +108.4% | 0.02% | -5.9% |
| Q4 2022 | $167,063,335 | +13.8% | 2,108,853 | +0.1% | 0.02% | +13.3% |
| Q3 2022 | $146,818,000 | +6.2% | 2,106,434 | +0.0% | 0.02% | +7.1% |
| Q2 2022 | $138,296,000 | -1.3% | 2,106,256 | -0.0% | 0.01% | +27.3% |
| Q1 2022 | $140,166,000 | +1.3% | 2,106,492 | +6.5% | 0.01% | +10.0% |
| Q4 2021 | $138,381,000 | +39.3% | 1,978,289 | +4.0% | 0.01% | +25.0% |
| Q3 2021 | $99,325,000 | -17.4% | 1,902,405 | +7.6% | 0.01% | -11.1% |
| Q2 2021 | $120,218,000 | +16.3% | 1,767,917 | +31.7% | 0.01% | 0.0% |
| Q1 2021 | $103,380,000 | +37.6% | 1,341,897 | +7.1% | 0.01% | +28.6% |
| Q4 2020 | $75,143,000 | +31.3% | 1,252,386 | -5.8% | 0.01% | +16.7% |
| Q3 2020 | $57,226,000 | +3.9% | 1,329,286 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $55,059,000 | +10.9% | 1,329,286 | +15.8% | 0.01% | -14.3% |
| Q1 2020 | $49,652,000 | -21.9% | 1,148,286 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $63,592,000 | +59.5% | 1,148,286 | 0.0% | 0.01% | +40.0% |
| Q3 2019 | $39,874,000 | -13.8% | 1,148,286 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $46,241,000 | +13.8% | 1,148,286 | -7.1% | 0.01% | 0.0% |
| Q1 2019 | $40,645,000 | +58.3% | 1,235,400 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $25,672,000 | +56.1% | 1,235,400 | +32.1% | 0.00% | +100.0% |
| Q3 2018 | $16,444,000 | -7.8% | 935,400 | -22.0% | 0.00% | 0.0% |
| Q2 2018 | $17,844,000 | +47.4% | 1,200,000 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $12,108,000 | -4.1% | 1,200,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $12,624,000 | +5.5% | 1,200,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $11,964,000 | – | 1,200,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |